Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes

Intervirology

Volumn 45, Issue 1, 2002, Pages 24-32

  Pumpens, Paul ^a,c   Razanskas, Raimundas ^b   Pushko, Peter ^a   Renhof, Regina ^a   Gusars, Indulis ^a   Skrastina, Dace ^a   Ose, Velta ^a   Borisova, Galina ^a   Sominskaya, Irina ^a   Petrovskis, Ivars ^a   Jansons, Juris ^a   Sasnauskas, Kestutis ^b  

^a UNIVERSITY OF LATVIA   (Latvia)

^b VILNIUS UNIVERSITY   (Lithuania)

^c LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

Human papillomavirus E7 oncoprotein; Immune response; Virus like particles

Indexed keywords

AMINO ACID; CARRIER PROTEIN; CHIMERIC PROTEIN; EPITOPE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; ONCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; TH1 CELL; TH2 CELL; VIRUS PARTICLE; WART VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAPSID; EPITOPES; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; RECOMBINANT FUSION PROTEINS; RNA PHAGES; VIRION;

ENTEROBACTERIA PHAGE FR; ESCHERICHIA COLI; HEPATITIS B VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 18344370048     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050084     Document Type: Article

References (51)

1. Papillomaviruses in human cancers
2. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
3. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: Interactions with nuclear and cytoplasmic target proteins
4. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen
5. Structural and functional characterization of the HPV16 E7 protein expressed in bacteria
6. Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients
7. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses
8. The E7 protein of human papillomavirus (HPV) type 16 expressed by recombinant vaccinia virus can be used for detection of antibodies in sera from cervical cancer patients
9. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment
10. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers
11. Natural HPV immunity and vaccination strategies
12. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice
13. Immunisation of mice using S. typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen
14. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region
15. Chimeric papillomavirus-like particles
16. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway
17. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
18. A 'public' T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes
19. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals
20. Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: A longitudinal study
21. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
22. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein
23. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16
24. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors
25. Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7
26. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: Conditions, efficiency, and relation to antibody responses
27. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide
28. Antigen engineering in yeast: Synthesis and assembly of hybrid hepatitis B surface antigen-herpes simplex 1 gD particles
29. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles
30. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
31. Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly
32. Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface
33. Genetically engineered mutants of the coat protein of RNA-containing bacteriophage fr
34. Analysis of RNA phage fr coat protein assembly by insertion, deletion and substitution mutagenesis
35. Human papillomavirus type 16 DNA sequence
36. Yeast cells allow the high-level expression and formation of polyomavirus-virus like particles
37. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes
38. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy
39. Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells
40. Computer-aided studies on the spatial structure of the small hepatitis B surface protein
41. Hepatitis B core particles as a universal display model: A structure-function basis for development
42. The crystal structure of the human hepatitis B virus capsid
43. Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: Implications for morphogenesis and organization of encapsidated RNA
44. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
45. The hepatitis B virus core and e antigens elicit different Th cell subsets: Antigen structure can affect Th cell phenotype
46. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
47. Brucella abortus as a potential vaccine candidate: Induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus
48. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model
49. Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term
50. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects
51. Crystal structure of bacteriophage fr capsids at 3.5 Å resolution